AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uusitupa, M. I.
Right arrow Articles by Kesaniemi, Y. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uusitupa, M. I.
Right arrow Articles by Kesaniemi, Y. A.
Agricola
Right arrow Articles by Uusitupa, M. I.
Right arrow Articles by Kesaniemi, Y. A.

American Journal of Clinical Nutrition, Vol 64, 131-136, Copyright © 1996 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Apolipoprotein E phenotype modifies metabolic and hemodynamic abnormalities related to central obesity in women

MI Uusitupa, L Karhunen, A Rissanen, A Franssila-Kallunki, L Niskanen, K Kervinen and YA Kesaniemi
Departments of Clinical Nutrition and Medicine, University of Kuopio, Finland.

Apolipoprotein E (apo E) is a normal constituent of very-low-density lipoproteins and it participates in the metabolism of both low-density lipoproteins (LDL) and apo E-containing lipoproteins. In the present study, the aim was to examine to what extent apo E phenotypes modify central obesity-induced changes in serum lipids, insulin, and blood pressure in obese women. Altogether, 143 middle-aged obese women with a body mass index (in kg/m2) of 28.0-43.0 were examined. Twelve had apo E 3,2 phenotype, 93 had apo E 3,3 phenotype, and 38 had either apo E 4,3 or 4,4 (4,3 + 4,4 group) phenotype. Serum total and LDL cholesterol were lower in the apo E 3,2 group than in other groups, but no significant differences were observed in other lipid variables in this regard. Both systolic and diastolic blood pressure measures tended to be lowest in subjects with apo E 3,2 phenotype and highest in those with apo E 4,3 or 4,4 phenotype (P = 0.08-0.15 for trend). When serum lipids, blood pressure, and insulin were analyzed by waist circumference and apo E phenotype group, it became evident that women who had central obesity and the apo E 4 allele had the highest blood pressures, insulin-glucose ratios, and insulin concentrations. These results suggest that apo E phenotype significantly modifies the central obesity-induced changes in metabolic and hemodynamic variables characteristic of insulin resistance.


This article has been cited by other articles:


Home page
Ann Clin BiochemHome page
E. Wardaningsih, T. Miida, U. Seino, Y. Fueki, M. Ito, K. Nagasaki, T. Kikuchi, M. Uchiyama, S. Hirayama, O. Hanyu, et al.
Low adiponectin state is associated with metabolic abnormalities in obese children, particularly depending on apolipoprotein E phenotype
Ann Clin Biochem, September 1, 2008; 45(5): 496 - 503.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. J Agren, H. M Vidgren, R. S Valve, M. Laakso, and M. I Uusitupa
Postprandial responses of individual fatty acids in subjects homozygous for the threonine- or alanine-encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene
Am. J. Clinical Nutrition, January 1, 2001; 73(1): 31 - 35.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Valve, K. Sivenius, R. Miettinen, J. Pihlajamaki, A. Rissanen, S. S. Deeb, J. Auwerx, M. Uusitupa, and M. Laakso
Two Polymorphisms in the Peroxisome Proliferator-Activated Receptor-{gamma} Gene Are Associated with Severe Overweight among Obese Women
J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3708 - 3712.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. P Simopoulos
Essential fatty acids in health and chronic disease
Am. J. Clinical Nutrition, September 1, 1999; 70(3): 560S - 569.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Heinonen, M. Koulu, U. Pesonen, M. K. Karvonen, A. Rissanen, M. Laakso, R. Valve, M. Uusitupa, and M. Scheinin
Identification of a Three-Amino Acid Deletion in the {alpha}2B-Adrenergic Receptor That Is Associated with Reduced Basal Metabolic Rate in Obese Subjects
J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2429 - 2433.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. J. Agren, R. Valve, H. Vidgren, M. Laakso, and M. Uusitupa
Postprandial Lipemic Response Is Modified by the Polymorphism at Codon 54 of the Fatty Acid–Binding Protein 2 Gene
Arterioscler. Thromb. Vasc. Biol., October 1, 1998; 18(10): 1606 - 1610.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. K. Karvonen, U. Pesonen, P. Heinonen, M. Laakso, A. Rissanen, H. Naukkarinen, R. Valve, M. I. J. Uusitupa, and M. Koulu
Identification of New Sequence Variants in the Leptin Gene
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3239 - 3242.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Rönnemaa, J. Marniemi, M. J. Savolainen, Y. A. Kesäniemi, C. Ehnholm, C. Bouchard, and M. Koskenvuo
Serum Lipids, Lipoproteins, and Lipid Metabolizing Enzymes in Identical Twins Discordant for Obesity
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2792 - 2799.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Sipilainen, M. Uusitupa, S. Heikkinen, A. Rissanen, and M. Laakso
Variants in the Human Intestinal Fatty Acid Binding Protein 2 Gene in Obese Subjects
J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2629 - 2632.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by The American Society for Nutrition